Clinical Trial

Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 20, 2025 (before its estimated September 21, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized controlled trial that aims to compare the effectiveness of two psychological treatment approaches: the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT). The study seeks to determine which of these two methods is more effective in reducing suicidal ideation and mental pain in individuals who have recently attempted suicide. In this study, 60 participants with a history of suicide attempts will be randomly assigned to three groups. One group will receive ASSIP in addition to treatment as usual (TAU), the second group will receive ACT alongside TAU, and the third group will be a control group receiving TAU only. The results will be assessed using the Beck Scale for Suicide Ideation (BSSI) and the Orbach \& Mikulincer Mental Pain Scale (OMMP) at three stages: pre-test, post-test, and follow-up. The ultimate goal of this research is to provide valuable insights into the comparative effectiveness of ASSIP and ACT interventions for suicide attempters and to contribute to evidence-based suicide prevention strategies. The findings are expected to inform clinical practice and guide future research in this field.
Trial Details
NCT Number NCT07132099
Lead Sponsor Ardakan University
Conditions Suicide, Suicide Ideation
Enrollment 60 participants
Start Date 2025-08-01
Primary Completion 2025-09-21 (estimated)
Study Completion 2025-10 (estimated)
Updated on ClinicalTrials.gov 2025-08-20